Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.

A multicenter, double-masked, randomized clinical investigation was conducted comparing 0.3% ofloxacin and 0.3% tobramycin for topical treatment of external ocular infection. One drop (1.35 micrograms) of either test solution was instilled six times daily for 2 days and thereafter four times daily for the next 8 days. At the day 3 to 5 follow-up examination, the severity of signs and symptoms based on a clinical summary score of 10 key variables was reduced from baseline values significantly (P less than .05) more with ofloxacin (-6.4 +/- 4.37; mean +/- SD) than with tobramycin (-4.78 +/- 3.13); by day 11, the difference between the groups was no longer significant. At days 3 to 5 and day 11 examinations, clinical, microbiologic, and overall improvement rates were similar, with no significant differences seen between the groups. Ofloxacin was found as effective, safe, and comfortable as tobramycin in patients with external ocular infection and may provide earlier symptom relief.

[1]  E. Lin,et al.  Ofloxacin in Human Serum, Urine, and Tear Film After Topical Application , 1992, Cornea.

[2]  D. Tang-Liu,et al.  Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms , 1990, Antimicrobial Agents and Chemotherapy.

[3]  J. Bosso,et al.  The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. , 1989, American journal of ophthalmology.

[4]  R. Turner,et al.  Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections , 1988, Antimicrobial Agents and Chemotherapy.

[5]  A. Nagayama,et al.  In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis. , 1988, Antimicrobial Agents and Chemotherapy.

[6]  I. Leopold,et al.  The potential use of quinolones in future ocular antimicrobial therapy. , 1988, American journal of ophthalmology.

[7]  M. Kresken,et al.  Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin , 1988, Antimicrobial Agents and Chemotherapy.

[8]  H. Lode,et al.  Pharmacokinetics of ofloxacin after parenteral and oral administration , 1987, Antimicrobial Agents and Chemotherapy.

[9]  A. Speciale,et al.  The sensitivity of gram-negative and gram-positive bacteria to ofloxacin. , 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[10]  S. Smith.  In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus , 1986, Antimicrobial Agents and Chemotherapy.

[11]  N. Brown,et al.  Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerases. , 1986, Drugs under experimental and clinical research.

[12]  H. Neu,et al.  In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents. , 1985, The Journal of antimicrobial chemotherapy.

[13]  A. Bryskier,et al.  Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison. , 1985, The Journal of antimicrobial chemotherapy.

[14]  I. Phillips,et al.  The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. , 1985, The Journal of antimicrobial chemotherapy.

[15]  H. Gelender,et al.  Gentamicin‐Resistant Pseudomonas aeruginosa Corneal Ulcers* , 1984, Cornea.

[16]  G. Krohel,et al.  Clinical inefficacy of tobramycin and gentamicin sulfate in the treatment of ocular infections. , 1984, Cornea.

[17]  S. Mitsuhashi,et al.  In vitro and in vivo activity of DL-8280, a new oxazine derivative , 1982, Antimicrobial Agents and Chemotherapy.

[18]  R. Abshire,et al.  Quantitative ocular bacteriology: a method for the enumeration and identification of bacteria from the skin-lash margin and conjunctiva. , 1981, Investigative ophthalmology & visual science.

[19]  S. Davis,et al.  Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study. , 1981, Current eye research.

[20]  Gary G. Koch,et al.  Average Partial Association in Three-way Contingency Tables: a Review and Discussion of Alternative Tests , 1978 .

[21]  N. Jarudi,et al.  Comparison of antibiotic therapy in presumptive bacterial conjunctivitis. , 1975, American journal of ophthalmology.